Axsome Therapeutics Inc. monthly returns
Axsome Therapeutics Inc. has averaged 5.22% a month with dividends reinvested, and risen in 49% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -5.9% | |
| Oct 2026 | -21.7% | |
| Sep 2026 | -7.1% | |
| Aug 2026 | -8.9% | |
| Jul 2026 | -10.9% | |
| Jun 2026 | +4.4% | |
| May 2026 | +12.9% | |
| Apr 2026 | +22.9% | |
| Mar 2026 | +3.1% | |
| Feb 2026 | -11.1% | |
| Jan 2026 | +0.9% | |
| Dec 2025 | +20.6% | |
| Nov 2025 | +12.2% | |
| Oct 2025 | +11.1% | |
| Sep 2025 | +0.1% | |
| Aug 2025 | +19.6% | |
| Jul 2025 | -2.9% | |
| Jun 2025 | -0.7% | |
| May 2025 | -6.3% | |
| Apr 2025 | -3.7% | |
| Mar 2025 | -8.6% | |
| Feb 2025 | +19.8% | |
| Jan 2025 | +25.8% | |
| Dec 2024 | -13.9% | |
| Nov 2024 | +10.3% | |
| Oct 2024 | -0.9% | |
| Sep 2024 | +1.1% | |
| Aug 2024 | +1.8% | |
| Jul 2024 | +8.5% | |
| Jun 2024 | +9.6% | |
| May 2024 | -0.4% | |
| Apr 2024 | -7.6% | |
| Mar 2024 | -1.9% | |
| Feb 2024 | -9.6% | |
| Jan 2024 | +13.1% | |
| Dec 2023 | +18.0% | |
| Nov 2023 | +8.3% | |
| Oct 2023 | -10.9% | |
| Sep 2023 | -13.5% | |
| Aug 2023 | +3.0% | |
| Jul 2023 | +9.2% | |
| Jun 2023 | -2.6% | |
| May 2023 | +3.1% | |
| Apr 2023 | +16.0% | |
| Mar 2023 | -9.5% | |
| Feb 2023 | -9.1% | |
| Jan 2023 | -2.8% | |
| Dec 2022 | +6.7% | |
| Nov 2022 | +60.1% | |
| Oct 2022 | +1.2% | |
| Sep 2022 | -30.1% | |
| Aug 2022 | +65.3% | |
| Jul 2022 | +0.8% | |
| Jun 2022 | +53.2% | |
| May 2022 | -21.3% | |
| Apr 2022 | -23.3% | |
| Mar 2022 | +47.2% | |
| Feb 2022 | +2.4% | |
| Jan 2022 | -27.4% | |
| Dec 2021 | +9.4% | |
| Nov 2021 | -10.3% | |
| Oct 2021 | +16.8% | |
| Sep 2021 | +28.3% | |
| Aug 2021 | -47.1% | |
| Jul 2021 | -28.0% | |
| Jun 2021 | +11.1% | |
| May 2021 | +0.4% | |
| Apr 2021 | +6.8% | |
| Mar 2021 | -15.9% | |
| Feb 2021 | -1.1% | |
| Jan 2021 | -16.4% | |
| Dec 2020 | +12.4% | |
| Nov 2020 | +9.3% | |
| Oct 2020 | -6.9% | |
| Sep 2020 | -2.8% | |
| Aug 2020 | +2.8% | |
| Jul 2020 | -13.3% | |
| Jun 2020 | +6.9% | |
| May 2020 | -19.0% | |
| Apr 2020 | +61.5% | |
| Mar 2020 | -24.6% | |
| Feb 2020 | -10.2% | |
| Jan 2020 | -16.0% | |
| Dec 2019 | +162.5% | |
| Nov 2019 | +63.5% | |
| Oct 2019 | +19.0% | |
| Sep 2019 | -20.5% | |
| Aug 2019 | -0.2% | |
| Jul 2019 | -1.0% | |
| Jun 2019 | +12.2% | |
| May 2019 | +29.5% | |
| Apr 2019 | +24.6% | |
| Mar 2019 | +78.8% | |
| Feb 2019 | -5.1% | |
| Jan 2019 | +197.5% | |
| Dec 2018 | -13.5% | |
| Nov 2018 | -15.8% | |
| Oct 2018 | +12.2% | |
| Sep 2018 | +0.0% | |
| Aug 2018 | +31.4% | |
| Jul 2018 | -18.0% | |
| Jun 2018 | -4.5% | |
| May 2018 | -1.5% | |
| Apr 2018 | +38.8% | |
| Mar 2018 | -3.9% | |
| Feb 2018 | -8.9% | |
| Jan 2018 | -50.0% | |
| Dec 2017 | -0.9% | |
| Nov 2017 | +18.9% | |
| Oct 2017 | -14.4% | |
| Sep 2017 | +8.8% | |
| Aug 2017 | -16.4% | |
| Jul 2017 | +10.9% | |
| Jun 2017 | +42.9% | |
| May 2017 | -6.1% | |
| Apr 2017 | +5.1% | |
| Mar 2017 | -14.3% | |
| Feb 2017 | -7.1% | |
| Jan 2017 | -27.4% | |
| Dec 2016 | +3.1% |
Monthly total return (since Dec 2021)#
Axsome Therapeutics Inc. returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -5.87% — 9th of 11 Novembers since 2015 at the last close; the average November returned +15.4%.
| Month | −200%0+200% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +7.4% | -15.5% | 36% | +197.5% 2019 | -50.0% 2018 | |
| Feb | -3.7% | -7.1% | 18% | +19.8% 2025 | -11.1% 2026 | |
| Mar | +5.6% | -3.9% | 36% | +78.8% 2019 | -24.6% 2020 | |
| Apr | +15.8% | +16.0% | 73% | +61.5% 2020 | -23.3% 2022 | |
| May | -3.6% | -1.5% | 36% | +29.5% 2019 | -31.4% 2016 | |
| Jun | +11.7% | +6.9% | 64% | +53.2% 2022 | -4.5% 2018 | |
| Jul | -3.7% | -1.0% | 45% | +10.9% 2017 | -28.0% 2021 | |
| Aug | +4.0% | +1.8% | 55% | +65.3% 2022 | -47.1% 2021 | |
| Sep | -2.4% | +0.0% | 45% | +28.3% 2021 | -30.1% 2022 | |
| Oct | -0.9% | -0.9% | 45% | +19.0% 2019 | -21.7% 2026 | |
| Nov | +15.4% | +9.8% | 70% | +63.5% 2019 | -15.8% 2018 | |
| Dec | +19.0% | +6.7% | 73% | +162.5% 2019 | -13.9% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from AXSM's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Axsome Therapeutics Inc.'s average monthly return?
- Axsome Therapeutics Inc. has averaged about 5.22% per month (dividends reinvested), positive in roughly 49% of months. The best month was Jan 2019 (+197.5%) and the worst was Jan 2018 (-50.0%).
